Cargando…
Single-Ascending-Dose Pharmacokinetic Study of Tribendimidine in Opisthorchis viverrini-Infected Patients
Praziquantel is the only drug available for the treatment of Opisthorchis viverrini infections. Tribendimidine has emerged as a potential treatment alternative; however, its pharmacokinetic (PK) properties have not been sufficiently studied to date. Via two phase IIa dose-finding studies, 68 O. vive...
Autores principales: | Duthaler, Urs, Sayasone, Somphou, Vanobbergen, Fiona, Penny, Melissa A., Odermatt, Peter, Huwyler, Jörg, Keiser, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038241/ https://www.ncbi.nlm.nih.gov/pubmed/27431234 http://dx.doi.org/10.1128/AAC.00992-16 |
Ejemplares similares
-
Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of Opisthorchis viverrini Infections
por: Meister, Isabel, et al.
Publicado: (2019) -
Population Pharmacokinetic Modeling of Tribendimidine Metabolites in Opisthorchis viverrini-Infected Adults
por: Vanobberghen, Fiona, et al.
Publicado: (2016) -
Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected Patients
por: Meister, Isabel, et al.
Publicado: (2016) -
Transmission of Opisthorchis viverrini, Schistosoma mekongi and soil-transmitted helminthes on the Mekong Islands, Southern Lao PDR
por: Vonghachack, Youthanavanh, et al.
Publicado: (2017) -
Spatial Distribution of, and Risk Factors for, Opisthorchis viverrini Infection in Southern Lao PDR
por: Forrer, Armelle, et al.
Publicado: (2012)